单侧烟雾病卒中结局的临床与神经影像因素
研究纳入393例单侧烟雾病患者(中位年龄40岁),平均随访68.9个月,43例(10.9%)发生卒中。多变量分析显示大脑后动脉受累、脑血流量减低及动脉壁同心圆强化与卒中显著相关,EDAS和大脑前交通动脉代偿供血为保护因素;单侧烟雾病可从EDAS获益并降低未来卒中风险。
要点
- 大脑后动脉受累(HR 2.199)、CBF减低(HR 2.292)、动脉壁同心圆强化(HR 3.093)与随访期卒中显著相关。
- EDAS(HR 0.385)与大脑前交通动脉代偿供血(HR 0.413)为卒中的保护因素。
- EDAS组卒中21/254(8.3%)低于保守治疗组22/139(15.8%)(P<0.05)。
核心结论
- 大脑后动脉受累、CBF减低、动脉壁同心圆强化、EDAS及大脑前交通动脉代偿供血可能有助于单侧烟雾病的卒中风险分层并改善治疗决策,单侧烟雾病可从EDAS获益且未来卒中风险较低。
研究设计与样本
- 在基线评估并平均随访68.9个月的单侧烟雾病患者393例(中位年龄40岁),计算缺血性与出血性卒中发生率,用单变量和多变量Cox比例风险模型计算卒中的HR及95%CI,用Kaplan-Meier乘积限法估计累积卒中风险。
关键影像表现/征象
- 动脉壁同心圆强化者随访期卒中风险显著升高(HR 3.093;95% CI 1.617-5.915)。
- 大脑后动脉受累者随访期卒中风险显著升高(HR 2.199;95% CI 1.100-4.398)。
- 大脑前交通动脉代偿供血者随访期卒中风险显著降低(HR 0.413;95% CI 0.206-0.830)。
诊断标准与关键数值
- CBF减低与随访期卒中显著相关(HR 2.292;95% CI 1.182-4.446)。
- EDAS与随访期卒中显著相关(HR 0.385;95% CI 0.203-0.730)。
- 随访期43例发生卒中(10.9%),儿童5/46(10.9%)与成人38/347(11.0%)无显著差异(P>0.05)。
- EDAS组卒中21/254(8.3%)vs 保守治疗组22/139(15.8%)(P<0.05)。
临床应用与阅片要点
- 作者认为大脑后动脉受累、CBF减低、动脉壁同心圆强化、EDAS及大脑前交通动脉代偿供血可能有助于单侧烟雾病的卒中风险分层并改善治疗决策。
- 作者认为单侧烟雾病可从EDAS获益且未来卒中风险较低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The clinical feature and long-term prognosis of unilateral moyamoya disease (MMD) have not been fully described and studied. The study aimed to investigate independent risk factors for stroke in unilateral MMD patients during a long-term follow-up.
MATERIALS AND METHODS: A total of 393 unilateral MMD patients (median age, 40 years) were assessed at baseline and followed for an average time of 68.9 months. Ischemic and hemorrhagic stroke incidence rates were determined. Multiple demographic, clinical and neuroimaging factors at baseline were considered as potential predictors of stroke during the follow-up period. Hazard ratios (HR) and corresponding 95% confidence interval (CI) for stroke were calculated by univariable and multivariable Cox proportional hazards models. Cumulative risk of stroke was estimated by the Kaplan-Meier product-limit method.
RESULTS: During the follow-up period, 43 patients experienced stroke events (10.9%). 5 children experienced stroke events (5/46, 10.9%) and 38 adults experienced stroke events (38/347, 11.0%) (P>0.05). 21 patients with encephaloduroarteriosynangiosis (EDAS) experienced stroke events (21/254, 8.3%) and 22 patients with conservative treatment experienced stroke events (22/139, 15.8%) (P<0.05). After adjustment for clinical characteristics, multivariable analysis showed that involvement of posterior cerebral artery (HR, 2.199; 95% CI, 1.100-4.398), decreased cerebral blood flow (CBF) (HR, 2.292; 95% CI, 1.182-4.446) and concentric enhancement of the arterial wall (HR, 3.093; 95% CI, 1.617-5.915) were significantly associated with stroke, and EDAS (HR, 0.385; 95% CI, 0.203-0.730) and compensatory blood supply by anterior communicating artery (HR, 0.413; 95% CI, 0.206-0.830) were protective factors for stroke.
CONCLUSION: Involvement of posterior cerebral artery, decreased CBF, concentric enhancement of the arterial wall, EDAS and compensatory blood supply by anterior communicating artery may help stratify the risk of stroke and improve therapeutic decisions in unilateral MMD. Unilateral MMD could benefit from EDAS and have a lower risk of future stroke.
引用
- Zhang H, Lu M, Liu S, et al. The Clinical and Neuroimaging Factors of Stroke Outcome of Unilateral Moyamoya Disease. Acad Radiol. 2025. PMID: 40382277. doi:10.1016/j.acra.2025.04.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。